Literature DB >> 23557831

The development and test of an intervention to improve ADR screening in nursing homes.

Tinne Dilles1, Robert H Vander Stichele, Lucas M Van Bortel, Monique M Elseviers.   

Abstract

OBJECTIVES: The aim of this study was to develop and test the effect of an instrument, Pharmanurse, to facilitate nurse-driven adverse drug reaction (ADR) screening as an input for interdisciplinary medication review in nursing homes.
DESIGN: Intervention study with a pre-posttest design PARTICIPANTS: All residents of a convenience sample of 8 nursing homes of more than 80 beds were eligible if they resided at least 1 month in the nursing home and took 4 or more different medications. Residents receiving palliative care were excluded. INTERVENTION: The intervention consisted of interdisciplinary medication review, prepared by nurse observations of potential ADRs using personalized screening lists generated by the Pharmanurse software. Pharmanurse is specifically adapted to use by nurses and to use in nursing homes. MEASUREMENTS: Outcome parameters were the number of ADRs detected by nurses, ADRs confirmed by general practitioners, and medication changes. After the intervention, health care professionals involved completed a questionnaire to evaluate the value and the feasibility of the intervention.
RESULTS: Nurses observed 1527 potential ADRs in 81% of the 418 residents (mean per resident 3.7). Physicians confirmed 821 ADRs in 60% of the residents (mean per resident 2.0). As a result, 214 medication changes were planned in 21% of the residents (mean per resident 0.5) because of ADRs. Health care professionals gave the Pharmanurse intervention a score of 7 of 10 for the potential to improve pharmacotherapy and 83% of the physicians were satisfied about nurses' screening for ADRs.
CONCLUSIONS: The Pharmanurse intervention supports nurses in ADR screening and may have the potential to improve pharmacotherapy.
Copyright © 2013 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23557831     DOI: 10.1016/j.jamda.2013.02.011

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  6 in total

Review 1.  Predicting risk of adverse drug reactions in older adults.

Authors:  Amanda Hanora Lavan; Paul Gallagher
Journal:  Ther Adv Drug Saf       Date:  2016-02

2.  Resident and nurse reports of potential adverse drug reactions.

Authors:  Tinne Dilles; Bart Van Rompaey; Peter Van Bogaert; Monique M Elseviers
Journal:  Eur J Clin Pharmacol       Date:  2015-04-24       Impact factor: 2.953

Review 3.  A 2014 medical informatics perspective on clinical decision support systems: do we hit the ceiling of effectiveness?

Authors:  J Bouaud; J-B Lamy
Journal:  Yearb Med Inform       Date:  2014-08-15

4.  Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT).

Authors:  Lorenz Van der Linden; Julie Hias; Lisa Dreessen; Koen Milisen; Johan Flamaing; Isabel Spriet; Jos Tournoy
Journal:  BMC Geriatr       Date:  2018-07-03       Impact factor: 3.921

5.  Did we do everything we could have? Nurses' contributions to medicines optimization: A mixed-methods study.

Authors:  Vera Logan; Sarah Keeley; Kevin Akerman; Elyne De Baetselier; Tinne Dilles; Nia Griffin; Lisa Matthews; Bart Van Rompaey; Sue Jordan
Journal:  Nurs Open       Date:  2020-10-24

Review 6.  Nurses and Pharmaceutical Care: Interprofessional, Evidence-Based Working to Improve Patient Care and Outcomes.

Authors:  Tinne Dilles; Jana Heczkova; Styliani Tziaferi; Ann Karin Helgesen; Vigdis Abrahamsen Grøndahl; Bart Van Rompaey; Carolien G Sino; Sue Jordan
Journal:  Int J Environ Res Public Health       Date:  2021-06-02       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.